Abstract Purpose of Commentary This commentary aims to offer a perspective on the effect
of tirzepatide on hypoxic burden and provide indirect evidence of cardiovascular risk …

Despite the availability of a wide range of antihypertensive agents, a significant proportion of
individuals with resistant hypertension (RHTN) struggle to achieve blood pressure (BP) …

Aims The prediction of future trends in cardiovascular disease (CVD) mortality and their risk
factors can assist policy-makers in healthcare planning. This study aims to project geospatial …

Background Given the rapidly growing burden of cardiovascular disease (CVD) in Asia, this
study forecasts the CVD burden and associated risk factors in Asia from 2025 to 2050 …

Obesity is currently considered a global epidemic, with rising prevalence worldwide and
rather pessimistic projections. Based on its close interconnection with various co …

Bariatric surgery is an important weight loss tool in individuals with severe obesity. It is
currently the most effective long-term weight loss treatment that lowers obesity-related …

Aims: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are employed extensively in
the management of type 2 diabetes and obesity. However, there is a paucity of real-world …

Aim Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) are at
increased risk of incident cardiovascular disease. However, the clinical characteristics and …

Objective Interventions that combat obesity and its associated metabolic perturbations may
decrease incidence and improve outcomes of endometrial cancer (EC). Potential options for …

There is a new awareness of the widespread nature of metabolic dysfunction–associated
steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This …